CTMX vs D · rev $138.1M vs P/E 21, rev $16.51B
CytomX Therapeutics Inc (CTMX) versus Dominion Energy Inc (D) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Dominion Energy Inc (D) is a utilities - regulated electric company listed on US.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
Latest reported D revenue for 2025-12-31 was $16.51B. Net income was $3.00B. Revenue was up 385.5% from 2024-12-31 to 2025-12-31. D currently screens at market cap $47.07B and trailing P/E 21.3.
CTMX currently screens at market cap $653.1M. D currently screens at market cap $47.07B and trailing P/E 21.3.
Not investment advice. Open the CTMX and D stock pages for the full models.
Not investment advice.